Influence of shear stress and size on viability of endothelial cells exposed to gold nanoparticles.

Screening nanoparticle toxicity directly on cell culture can be a fast and cheap technique. Nevertheless, to obtain results in accordance with those observed in live animals, the conditions in which cells are cultivated should resemble the one encountered in live systems. Microfluidic devices offer the possibility to satisfy this requirement, in particular with endothelial cell lines, because they are capable to reproduce the flowing media and shear stress experienced by these cell lines in vivo. In this work, we exploit a microfluidic device to observe how human umbilical vein endothelial cells (HUVEC) viability changes when subject to a continuous flow of culture medium, in which spherical citrate-stabilized gold nanoparticles of different sizes and at varying doses are investigated. For comparison, the same experiments are also run in multiwells where the cells do not experience the shear stress induced by the flowing medium. We discuss the results considering the influence of mode of exposure and nanoparticle size (24 and 13 nm). We observed that gold nanoparticles show a lower toxicity under flow conditions with respect to static and the HUVEC viability decreases as the nanoparticle surface area per unit volume increases, regardless of size.

An easy-to-handle microfluidic device suitable for immunohistochemical procedures in mammalian cells grown under flow conditions.

Microfluidic, the technology that manipulates small amount of fluids in microscale complex devices, has undergone a remarkable development during the last decade, by targeting a significant range of applications, including biological tests and single-cell analysis, and by displaying many advantages such as reduced reagent consumption, decreased costs and faster analysis. Furthermore, the introduction of microfluidic tools has revolutionized the study of vascular functions, because the controlled three-dimensional environment and the continuous perfusion provided by the microdevice allow simulating the physiological characteristics of the circulatory system. Researchers interested in the study of vascular physiology, however, are often hampered by the difficulty in handling reduced number of cells after growth in these devices. This work shows how to apply different protocols commonly used in biology, such as the immunofluorescence technique, to cells grown in reversibly-bound microfluidic devices, obtaining results comparable to those retrieved under static conditions in multiwells. In this way, we are able to combine the advantages of microfluidic, i.e., application of continuous flow and shear stress, with classical protocols for the study of endothelial cells.

Dimers of polar chromophores in solution: role of excitonic interactions in one- and two-photon absorption properties.

The possibility to exploit a bottom-up approach to design and synthesize multichromophoric structures from a single molecular unit is strategic for the targeted synthesis of molecular compounds with well defined linear and nonlinear absorption properties. In this view, it is important to be able to predict the properties of multichromophoric units, based on the knowledge of the properties of the individual chromophores and their mutual arrangement. To this end, we present a combined experimental and theoretical study on 4-(para-di-n-butylaminostyryl)-pyridine, a push-pull molecule, and its dimer, 4,4'-bis(para-di-n-butylaminostyryl)-2,2'-bipyridine, formed by connecting the two pyridine groups into a bipyridine structure. One photon absorption and fluorescence spectra are measured in solvents of different polarity, and two-photon absorption spectra are recorded in dichloromethane. Experimental results are compared with results of TDDFT (Time-Dependent Density Functional Theory) and CIS (Configuration Interaction with Single excitation) methods implemented in the Gaussian03 program suite. An essential-state analysis of optical spectra is used to rationalize the observed behavior.